DMKPQ (DMK Pharmaceuticals) FCF Margin %: -41,522.22% (As of Sep. 2023)


DMKPQ DMK Pharmaceuticals Corp DMKPQ
16 GF Score
Price $0.00
View Full Analysis

What is DMK Pharmaceuticals FCF Margin %?

DMK Pharmaceuticals DMKPQ -99.00% 16 FCF Margin % is -41,522.22% as of Sep. 2023. GuruFocus rates DMKPQ with a GF Score™ of 16/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. DMK Pharmaceuticals's Free Cash Flow for the three months ended in Sep. 2023 was $-3.74 Mil. DMK Pharmaceuticals's Revenue for the three months ended in Sep. 2023 was $0.01 Mil. Therefore, DMK Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2023 was -41,522.22%.

As of today, DMK Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for DMK Pharmaceuticals's FCF Margin % or its related term are showing as below:

DMKPQ' s FCF Margin % Range Over the Past 10 Years
Min: -261.52   Med: 0   Max: 0
Current: -261.52

DMKPQ's FCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.445 vs DMKPQ: -261.52

DMK Pharmaceuticals FCF Margin % Related Terms

DMK Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for DMK Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMK Pharmaceuticals FCF Margin % Chart

DMK Pharmaceuticals Annual Data
Trend Mar13 Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -239.90 -102.89 -777.85 -1,765.87 -558.89

DMK Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -511.69 -74.99 -106.54 -36,700.00 -41,522.22

DMKPQ vs CNNC, THCT, VFRM: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, DMK Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DMK Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DMK Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where DMK Pharmaceuticals's FCF Margin % falls into.


DMKPQ
16GF Score
DMK Pharmaceuticals Corp DMKPQ
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DMK Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

DMK Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-26.581/4.756
=-558.89 %

DMK Pharmaceuticals's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-3.737/0.009
=-41,522.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -41,522.22% mean?
DMK Pharmaceuticals (DMKPQ) has a FCF Margin % of -41,522.22% as of Sep. 2023. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DMK Pharmaceuticals and its competitors.
Is DMK Pharmaceuticals' FCF Margin % too high?
DMK Pharmaceuticals' current FCF Margin % is -41,522.22%. Overall, DMK Pharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does DMK Pharmaceuticals' FCF Margin % compare to CNNC and THCT?
DMK Pharmaceuticals' FCF Margin % of -41,522.22% can be compared against companies in the Drug Manufacturers industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on DMK Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DMK Pharmaceuticals's current FCF Margin % is -41,522.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DMK Pharmaceuticals stock overvalued right now?
DMK Pharmaceuticals (DMKPQ) has a current FCF Margin % of -41,522.22%. The current FCF Margin % is -41,522.22%. DMK Pharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For DMK Pharmaceuticals (DMKPQ), the current FCF Margin % is -41,522.22% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DMK Pharmaceuticals Business Description

Address 11682 El Camino Real, Suite 300, San Diego, CA, USA, 92130
DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-400) intended for the treatment of Covid-19.
16GF Score

Get the complete analysis for DMKPQ

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price